[Subcapsular orchiectomy in the treatment of prostate cancer: results].
To analyze the role of orchiectomy in the management of metastasic prostate cancer in our environment. We studied 76 patients with the diagnosis of prostate cancer who underwent subcapsular orchiectomy. Mean age was 72 years, median Gleason score was 7, and only 17% had organ confined tumors. Mean follow-up was 2.3 yr. and hospital stay median three days. Ten of the 76 patients in the study died from cancer, being overall five-year survival 75%. Regarding cost analysis, surgical castration was cheaper in the long-term but has the disadvantage of its greater psychological impact. Orchiectomy is a valid hormonal blockade option when estimated patient survival is longer than one year.